Chemoinformaics analysis of D-ALPHA-OXYGLUTARIC-ACID
Molecular Weight | 250.338 | nRot | 2 |
Heavy Atom Molecular Weight | 228.162 | nRig | 14 |
Exact Molecular Weight | 250.157 | nRing | 2 |
Solubility: LogS | -2.91 | nHRing | 0 |
Solubility: LogP | 1.707 | No. of Aliphatic Rings | 2 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 18 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 42.1254 |
nHD | 1 | BPOL | 23.8066 |
QED | 0.766 |
Synth | 4.018 |
Natural Product Likeliness | 2.55 |
NR-PPAR-gamma | 0.022 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.002 |
Pgp-sub | 0 |
HIA | 0.024 |
CACO-2 | -4.868 |
MDCK | 0.0000138 |
BBB | 0.135 |
PPB | 0.905057 |
VDSS | 0.332 |
FU | 0.0588733 |
CYP1A2-inh | 0.039 |
CYP1A2-sub | 0.797 |
CYP2c19-inh | 0.022 |
CYP2c19-sub | 0.666 |
CYP2c9-inh | 0.119 |
CYP2c9-sub | 0.526 |
CYP2d6-inh | 0.007 |
CYP2d6-sub | 0.378 |
CYP3a4-inh | 0.022 |
CYP3a4-sub | 0.182 |
CL | 7.439 |
T12 | 0.812 |
hERG | 0.011 |
Ames | 0.022 |
ROA | 0.157 |
SkinSen | 0.051 |
Carcinogencity | 0.535 |
EI | 0.11 |
Respiratory | 0.849 |
NR-Aromatase | 0.014 |
Antiviral | Yes |
Prediction | 0.917034 |